Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2016 12
2017 26
2018 32
2019 36
2020 23
2021 37
2022 49
2023 38
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review.
Huang J, Li T, Tan Z, Tang Y, Li J, Liu F, Shi W. Huang J, et al. Acta Derm Venereol. 2023 Sep 20;103:adv13418. doi: 10.2340/actadv.v103.13418. Acta Derm Venereol. 2023. PMID: 37731213 Free PMC article. Review.
Alopecia areata (AA) is a common cause of hair loss in children. Despite numerous therapeutic options for paediatric AA, none have been found to be both effective and safe. ...Overall, 82% (9/11) of patients experienced hair regrowth and 64% (7/11) of patients experienced …
Alopecia areata (AA) is a common cause of hair loss in children. Despite numerous therapeutic options for paediatric AA, none have be …
Efficacy and safety of tofacitinib for treatment of alopecia areata in children: A systematic review and meta-analysis.
Behrangi E, Barough MS, Khoramdad M, Hejazi P, Koltapeh MP, Goodarzi A. Behrangi E, et al. J Cosmet Dermatol. 2022 Dec;21(12):6644-6652. doi: 10.1111/jocd.15425. Epub 2022 Oct 24. J Cosmet Dermatol. 2022. PMID: 36177815 Review.
BACKGROUND: Tofacitinib, a potent JAK inhibitor, has gained increasing interest, in recent years, among dermatologists for the management of refractory alopecia areata. ...Few side effects such as diarrhea and mild liver transaminases abnormalities were noted in sev …
BACKGROUND: Tofacitinib, a potent JAK inhibitor, has gained increasing interest, in recent years, among dermatologists for the manage …
Refractory alopecia in lupus treated with tofacitinib - a case-based review.
Sarkar R, Mv P, Hinduja N, Sethy M, Kar H, Ahmed S. Sarkar R, et al. Clin Rheumatol. 2023 Aug;42(8):2237-2241. doi: 10.1007/s10067-023-06632-6. Epub 2023 May 15. Clin Rheumatol. 2023. PMID: 37188961 Review.
One of the common cutaneous symptoms of systemic lupus erythematosus (SLE) that may have major psychosocial effects in a female is diffuse alopecia. Although Janus kinase inhibitors have shown encouraging results in the treatment of SLE and of alopecia areata in rec …
One of the common cutaneous symptoms of systemic lupus erythematosus (SLE) that may have major psychosocial effects in a female is diffuse …
Which is the Ideal JAK Inhibitor for Alopecia Areata - Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway.
Sardana K, Bathula S, Khurana A. Sardana K, et al. Indian Dermatol Online J. 2023 Jun 28;14(4):465-474. doi: 10.4103/idoj.idoj_452_22. eCollection 2023 Jul-Aug. Indian Dermatol Online J. 2023. PMID: 37521227 Free PMC article. Review.
Alopecia areata (AA) is an immune-mediated condition, clinically manifesting as non-cicatricial patches of alopecia. ...Moreover, the response achieved with JAKibs is not sustained after treatment discontinuation, with many studies showing a high recurrence rate wit …
Alopecia areata (AA) is an immune-mediated condition, clinically manifesting as non-cicatricial patches of alopecia. ...Moreov …
Janus kinase inhibitors for alopecia areata.
King BA, Craiglow BG. King BA, et al. J Am Acad Dermatol. 2023 Aug;89(2S):S29-S32. doi: 10.1016/j.jaad.2023.05.049. J Am Acad Dermatol. 2023. PMID: 37591562 Review.
Janus kinase (JAK) inhibitors have ushered in a new era in alopecia areata (AA). Historically, moderate-to-severe AA was refractory to treatment. ...
Janus kinase (JAK) inhibitors have ushered in a new era in alopecia areata (AA). Historically, moderate-to-severe AA was refractory t …
Emerging drugs for the treatment of alopecia areata.
Ramírez-Marín HA, Tosti A. Ramírez-Marín HA, et al. Expert Opin Emerg Drugs. 2022 Dec;27(4):379-387. doi: 10.1080/14728214.2022.2149735. Epub 2022 Nov 21. Expert Opin Emerg Drugs. 2022. PMID: 36408593 Review.
INTRODUCTION: Alopecia Areata (AA) is the second most common non-scarring hair loss disorder, with a prevalence of 1 in 1000 and a lifetime incidence of 2% worldwide. ...
INTRODUCTION: Alopecia Areata (AA) is the second most common non-scarring hair loss disorder, with a prevalence of 1 in 1000 and a li …
Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents.
Liu LY, King BA. Liu LY, et al. J Investig Dermatol Symp Proc. 2018 Jan;19(1):S18-S20. doi: 10.1016/j.jisp.2017.10.003. J Investig Dermatol Symp Proc. 2018. PMID: 29273099 Free article. Review.
Alopecia areata (AA) is an autoimmune disease affecting people of all ages. ...This review summarizes the results of long-term use of tofacitinib in severe AA....
Alopecia areata (AA) is an autoimmune disease affecting people of all ages. ...This review summarizes the results of long-term use of …
Systematic review - alopecia areata and tofacitinib in paediatric patients.
Bandeira A, Albino-Teixeira A, Magina S. Bandeira A, et al. Cutan Ocul Toxicol. 2022 Jun;41(2):194-201. doi: 10.1080/15569527.2022.2084622. Epub 2022 Jun 10. Cutan Ocul Toxicol. 2022. PMID: 35687530
It is a chronic autoimmune disorder with a severe psychological impact in patients' lives. JAK inhibitors, in particular Tofacitinib, have been having promising results on Alopecia Areata Treatment. In this study we aimed to do a Systematic Review on the role of …
It is a chronic autoimmune disorder with a severe psychological impact in patients' lives. JAK inhibitors, in particular Tofacitinib, …
Resistant Alopecia Areata Treated with Tofacitinib.
Sahay G. Sahay G. Int J Trichology. 2022 Sep-Oct;14(5):181-182. doi: 10.4103/ijt.ijt_63_22. Epub 2022 Oct 7. Int J Trichology. 2022. PMID: 36404885 Free PMC article.
Several reports more so from western countries present recovery for alopecia areata (AA) with tofacitinib. In this report, we present the case of a young adult male diagnosed with resistant AA with failed treatment to oral as well topical steroids, minoxidil, and or …
Several reports more so from western countries present recovery for alopecia areata (AA) with tofacitinib. In this report, we …
232 results

Searches related to "tofacitinib alopecia"